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Abstract: Although ginsenosides Rb1 and Rg3 have been identified as the significant ginsenosides
found in red ginseng that confer anti-diabetic actions, it is unclear whether insulin-sensitizing effects
are mediated by the individual compounds or by their combination. To determine the effect of
ginsenosides Rb1 and Rg3 on adipocyte differentiation, 3T3-L1 preadipocytes were induced to
differentiate the standard hormonal inducers in the absence or presence of ginsenosides Rb1 or
Rg3. Additionally, we determined the effects of Rb1, Rg3, or their combination on the expression of
genes related to adipocyte differentiation, adipogenic transcription factors, and the insulin signaling
pathway in 3T3-L1 cells using semi-quantitative RT-PCR. Rb1 significantly increased the expression
of CEBPα, PPARγ, and aP2 mRNAs. However, Rg3 exerted its maximal stimulatory effect on
these genes at 1 µM concentration, while a high concentration (50 µM) showed inhibitory effects.
Similarly, treatment with Rb1 and Rg3 (1 µM) increased the expression of IRS-1, Akt, PI3K, GLUT4,
and adiponectin. Importantly, co-treatment of Rb1 and Rg3 (9:1) induced the maximal expression
levels of these mRNAs. Our data indicate that the anti-diabetic activity of red ginseng is, in part,
mediated by synergistic actions of Rb1 and Rg3, further supporting the significance of minor Rg3.
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1. Introduction
Enlarged adipocytes and excess adiposity play a key role in the metabolic and cardiovascular complications associated with obesity [1]. Our current understanding is that
hypertrophic obesity is strongly associated with obesity-related insulin resistance and
type 2 diabetes (T2D), while hyperplastic obesity is not usually linked to these metabolic
consequences, which are seen in 20–30% of obese individuals characterized as “obese
but metabolically normal” [2–5]. This clearly suggests that impaired formation of new
adipocytes through preadipocyte differentiation (i.e., adipogenesis) is linked to the pathological expansion of adipose tissue (AT), as evidenced by decreases in insulin sensitivity and
expression of mRNAs by differentiation markers such as peroxisome proliferator-activated
receptor (PPARγ), glucose transporter 4 (GLUT4), and adiponectin [6,7]. Moreover, a hypertrophic environment also leads to AT dysfunction by impairing adipocyte insulin signaling
pathways, thereby promoting insulin resistance [8,9]. Consequently, the hyperplasic expansion of adipocytes over hypertrophic enlargement within an individual can counteract
the negative metabolic effects of obesity, and has an enormous impact on metabolic health
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outcomes. Accordingly, adipocytes have recently been emerging as a therapeutic target for obesity-associated metabolic disorders and thus introducing agents that promote
preadipocyte differentiation and/or lipid oxidation would be a promising strategy for
obesity-induced metabolic disorders.
Panax ginseng Meyer is believed to be a panacea, used in traditional oriental medicine
for over 2000 years primarily to enhance physical and mental performance [10,11]. The pharmacological properties of ginseng and its constituents depend on the type and site of the
attached sugar moieties, and have been largely attributed to ginsenosides [12–14]. Historically, raw ginseng is processed into either white ginseng by a simple drying method or red
ginseng by a steaming process to enhance its shelf-life and efficacy [15–17]. Red ginseng is
known to have a distinct ginsenoside profile compared to white and raw ginseng in the
content and composition of ginsenosides [18–20]. In particular, red ginseng is shown to
be rich in ginsenoside Rg3, which is significantly increased during the steaming process,
whereas ginsenoside Rb1, the most abundant ginsenoside in ginseng root, is relatively
reduced in steamed red ginseng [15,20–23]. Recent studies have shown that ginsenoside
Rb1 is deglycosylated by human intestinal bacteria or digestive enzymes and is converted
to a minor metabolite form, Rg3 [24,25]. It is also reported that deglycosylated ginsenoside
metabolites are more readily absorbed into the blood stream and thus act as biologically
active compounds [26]. Clinical and pre-clinical studies have also shown that ginseng
extract and ginsenosides exert anti-diabetic effects by lowering blood glucose levels and
enhancing insulin sensitivity [27,28]. Similarly, ginsenosides Rb1 and Rg3 have been reported to possess anti-diabetic effects, mainly through blood glucose control in animals and
the stimulation of glucose uptake in 3T3-L1 mature adipocytes and L6 myotubes [29–34].
However, there have been contradictory results that Rb1 induces adipocyte differentiation,
whereas Rg3 inhibits it, which may be due to the differences in the concentrations of
ginsenosides and different cell culture models used in various studies [30,34–38]. In addition, no comparative studies have been reported for the potential bioactivity of Rb1 in
combination with its metabolite, Rg3.
The aim of this study was to investigate the effect of the individual, as well as the
combination of, ginsenosides Rb1 and Rg3 on adipocyte differentiation, glucose transport
systems, adiponectin, and the insulin signaling pathway using a well-established model
of adipocyte differentiation, 3T3-L1 preadipocytes. In the present study, we measured
the expression levels of key molecules involved in the adipogenic program and insulin
signaling pathways potentially regulated by the major ginsenosides Rb1 and Rg3. We also
assessed the synergistic effects of Rb1 and Rg3, which are important for elucidating the
effect of these important bioactives on T2D and its mechanism of action.
2. Materials and Methods
2.1. Cell Line and Materials
3T3-L1 cells were purchased from American Type Culture Collection (ATCC, CL-173,
Manassas, VA, USA). Penicillin-streptomycin (P/S), trypsin-EDTA, phosphate-buffered
saline (PBS), fetal bovine serum (FBS), bovine calf serum (BCS), and Dulbecco’s modified
Eagle’s medium (DMEM) were obtained from Gibco (Gaithersburg, MD, USA). Ginsenosides Rb1 and Rg3 were purchased from Fleton Reference Substance Co., Ltd. (Chengdu,
China), and dissolved in dimethyl sulfoxide (DMSO). Unless noted otherwise, all chemicals
were purchased from Sigma (St. Louis, MO, USA).
2.2. Cell Culture
3T3-L1 preadipocytes were cultured using the method of Blumberg et al. [39]. Briefly,
cells were plated and grown for 2 days post-confluence in DMEM with 10% BCS, 1%
P/S, and 3.7 g/L sodium bicarbonate. Adipocyte differentiation was induced by treating
confluent cells with MDI cocktail (0.5 mM IBMX, 1 µM Dex, and 1.67 µM insulin) and
10% FBS for 2 days. The culture medium was then replaced with DMEM supplemented
with only 10% FBS and 1.67 µM insulin. Two days after the addition of 10% FBS and MDI,
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the cells were treated with ginsenosides Rb1 and Rg3 individually (1, 10, and 50 µM) or in
combination (10 µM). The cell culture medium was changed on alternate days with DMEM
containing 10% FBS and insulin (1.67 µM) with ginsenosides Rb1 and Rg3.
2.3. Determination of Lipid Accumulation by Oil Red O Staining
The extent of differentiation was determined by the amount of lipid accumulation
at 0, 4, and 6 days by Oil red O staining. Briefly, cells were fixed in formaldehyde (10%
v/v) for 1 h. Cells were stained with 0.5% Oil red O solution in 60% (v/v) isopropanol at
room temperature for 30 min, washed with distilled water, and dried. Differentiation was
monitored under a phase-contrast microscope and quantified via elution with isopropanol,
and optical density was measured at 490 nm (OD490 ) [39].
2.4. RNA Analysis by Semi-Quantitative Reverse Transcriptase Polymerase Reaction (RT-PCR)
Total RNA was isolated from 3T3-L1 adipocyte cells using TRIzol reagent (Invitrogen,
Carlsbad, CA, USA). The cDNAs were synthesized with the SuperScript First-Strand
Synthesis system for RT-PCR kit (Invitrogen), performed using 30 to 35 cycles of 30 s at
94 ◦ C, 30 sec at 55 ◦ C, and 1 min at 72 ◦ C, followed by 10 min extension at 72 ◦ C. All primers
used in this study are listed in Table 1. To ensure that equal amounts of reverse-transcribed
cDNA were applied, β-actin was used as a housekeeping gene. Image-J (version 1.28 u,
National Institutes of Health, Washington, DC, USA) was used to measure the intensity of
the PCR products.
Table 1. Gene-specific primers used for RT-PCR.
Primer Sequences (50 →30 )
PPARγ

Forward
Reverse

CCA GAG TCT GCT GAT CTG CG
GCC ACC TCT TTG CTC TGA TC

C/EBP α

Forward
Reverse

GGT GCG CAA GAG CCG AGA TAA AG
AGT TCA CGG CTC AGC TGT TCC AC

aP2

Forward
Reverse

GAC CTG GAA ACT CGT CTC CA
CAT GAC ACA TTC CAC CAC CA

GLUT4

Forward
Reverse

TAC TCA TTC TTG GAC GGT TC
TGA TGT AGA GGT ATC TGG GG

adiponectin

Forward
Reverse

AAG GAC AAG GCCG TTC TCT
TAT GGG TAG TTG CAG TCA GTT GG

IRS-1

Forward
Reverse

TCG TCA ATA GCG TAA CTG GA
AGA ACG TGC AGT TCA GTC AA

PI3K

Forward
Reverse

CAT GTT CTG GAA ACT TCA CCA
CCT GGG GAA ACA TAA ACT TG

Akt

Forward
Reverse

AGA GAT GGG GAT AGG TGT CT
ACT CAC ACA AGT CTG CAT A

β-actin

Forward
Reverse

AGG CTG TGC TGT CCC TGT ATG C
ACC CAAG AAG GAA GGC TGG AAA

2.5. Statistical Analysis
The results are expressed as means ± standard deviations and statistically analyzed
by ANOVA and Duncan’s multiple range tests. Statistical significance was set at p < 0.05
(SAS Inst., Inc., Cary, NC, USA).
3. Results
3.1. Ginsenosides Rb1 and Rg3 Enhanced the Differentiation of 3T3-L1 Preadipocytes
To determine the effect of ginsenosides Rb1 and Rg3 on adipocyte differentiation, 3T3L1 preadipocytes were induced to differentiate with the standard hormonal inducers (MDI)

Appl. Sci. 2021, 11, x FOR PEER REVIEW

Appl. Sci. 2021, 11, 1725

4 of 11

4 of 10

3. Results
3.1. Ginsenosides Rb1 and Rg3 Enhanced the Differentiation of 3T3-L1 Preadipocytes

To determine the effect of ginsenosides Rb1 and Rg3 on adipocyte differentiation,
3T3-L1 preadipocytes were induced to differentiate with the standard hormonal inducers
in the absence or presence of ginsenosides Rb1 or Rg3 (1, 10, and 50 µM), as described
(MDI) in the absence or presence of ginsenosides Rb1 or Rg3 (1, 10, and 50 μM), as dein the Methods. The range of concentrations was chosen to consider physiologically
scribed in the Methods. The range of concentrations was chosen to consider physiologiachievable doses (1 and 10 µM) and a nontoxic high dose of ginsenosides (50 µM) [40–42].
cally achievable doses (1 and 10 μM) and a nontoxic high dose of ginsenosides (50 μM)
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1. Effect of ginsenoside Rb1 and Rg3 on adipocyte conversion during the differentiation of 3T3-L1 preadipocytes.
Figure Figure
1. Effect
of ginsenoside Rb1 and Rg3 on adipocyte conversion during the differentiation of 3T3-L1 preadipocytes.
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Figure 2. Changes in the expression of PPARγ, CEBPα, and aP2 mRNAs by ginsenosides Rb1 and Rg3 during the differ-

Figure 2. Changes in the expression of PPARγ, CEBPα, and aP2 mRNAsa–dby ginsenosides Rb1 and Rg3 during the
entiation of 3T3-L1 preadipocytes. Values are the means ± SDs of four samples. Bars with different letters indicate stadifferentiation
ofsignificant
3T3-L1 preadipocytes.
Values
areatthe
means ± SDs of four samples. a–d Bars with different letters indicate
tistically
differences among
groups
p < 0.05.
statistically significant differences among groups at p < 0.05.
3.2. Ginsenosides Rb1 and Rg3 Upregulate GLUT4 and Adiponectin mRNA Expression
Since PPARγ is a molecular target for anti-diabetic drugs, such as thiazolidinediones
(TZDs), that enhance glucose uptake and insulin sensitivity, we next examined whether
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Figure 2. Changes in the expression of PPARγ, CEBPα, and aP2 mRNAs by ginsenosides Rb1 and Rg3 during the differentiation of 3T3-L1 preadipocytes. Values are the means ± SDs of four samples. a–d Bars with different letters indicate sta3.2. Ginsenosides Rb1 and Rg3 Upregulate GLUT4 and Adiponectin mRNA Expression
tistically significant differences among groups at p < 0.05.
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(a)

(b)

Figure 3. Changes of GLUT4 and adiponectin mRNAs expression by ginsenosides Rb1 and Rg3 during the differentiation
Figure 3. Changes
of GLUT4 and adiponectin mRNAs expression by ginsenosides Rb1 and Rg3 during the differentiation
of 3T3-L1 preadipocytes. Values are the means ± SD of four samples. a–e Bars with different letters indicate statistically
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significant differences among groups at p < 0.05.
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3.3. Ginsenosides Rb1 and Rg3 Increase mRNA Expression of the Glucose Transport System
Glucose uptake is regulated by the glucose transport system, which involves insulin
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Figure 4. Changes of IRS-1, Akt, and PI3K mRNAs expression by ginsenoside Rb1 and Rg3 during the differentiation of
Figure 4. Changes
of IRS-1, Akt,
andare
PI3K
mRNAs
expression
by ginsenoside
Rb1 and
Rg3
during
the differentiation
of
a–e Bars with different
3T3-L1 preadipocytes.
Values
the means
± SDs
of four samples.
letters
indicate
statistically
significant differences
among
at p < 0.05.
3T3-L1 preadipocytes.
Values
aregroups
the means
± SDs of four samples. a–e Bars with different letters indicate statistically

significant differences among groups at p < 0.05.

3.4. Combined Effects of Ginsenosides Rb1 and Rg3 on the Expression of GLUT4 and
Adiponectin mRNAs
Ginsenoside Rb1 has been shown convert into ginsenoside Rg3 by conversion processes such as steaming or contact with intestinal bacteria [18]. As shown in Figure 5, the
combined treatment of Rb1 and Rg3 (9:1 ratio) markedly increased the expression of
GLUT4 and adiponectin mRNAs. However, decreasing the ratio of Rb1 to Rg3 by increas-
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Figure 4. Changes of IRS-1, Akt, and PI3K mRNAs expression by ginsenoside Rb1 and Rg3 during the differentiation of
3T3-L1 preadipocytes. Values are the means ± SDs of four samples. a–e Bars with different letters indicate statistically significant differences among groups at p < 0.05.

3.4. Combined Effects of Ginsenosides Rb1 and Rg3 on the Expression of GLUT4 and Adiponectin
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Figure 5. Effect of combined ginsenosides Rb1 and Rg3 on the expression of GLUT4 and adiponectin mRNAs expression
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during the differentiation of 3T3-L1 preadipocytes. Values are the means ± SDs of four samples.
Bars with different
letters indicate statistically significant differences among groups at p < 0.05.

3.5. Combined Effects of Ginsenosides Rb1 and Rg3 on the Insulin Signaling Pathway
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Figure
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4. Discussion
The biological activities of ginseng have been largely attributed to ginsenosides produced by different processing methods and/or biotransformation by human intestinal
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4. Discussion
The biological activities of ginseng have been largely attributed to ginsenosides produced by different processing methods and/or biotransformation by human intestinal
bacteria [16,17,24]. Although Rb1 is the most abundant ginsenoside in ginseng root and
white ginseng, red ginseng produced by a steaming process substantially increases the
concentration of Rg3, which is also known to be produced by human intestinal bacteria
from Rb1 [22–24]. Several studies have therefore been aimed at converting ginsenoside
Rb1 to Rg3 by various methods, including steaming, fermentation, or acidic and enzymatic
treatments [15,46]. However, few studies have investigated the anti-diabetic potential of
Rb1 in combination with Rg3, which may better reflect actual human consumption and
thus biological activities.
Intervention studies in humans and animals have demonstrated that ginseng extracts
and ginsenosides improve insulin sensitivity [47,48]. In vitro studies have also shown
their modulatory effects on PPARγ, a nuclear receptor for anti-diabetic drugs, and the
expression of its downstream target genes [36,38]. However, literature on the effect of
specific ginsenosides Rb1 or Rg3 on adipocyte differentiation and function is currently
inconsistent and unclear. Some studies have reported inhibitory effects of ginsenosides on
PPARγ expression and adipocyte differentiation [30,34,35], while other studies have shown
stimulatory effects [36–38]. These contradictory results from different studies might be
attributable to differences in the concentrations of ginsenosides used (i.e., inhibitory with
high and stimulatory with low concentrations), cell culture models (i.e., differentiating vs.
mature adipocytes), and/or experimental conditions.
In the present study, we found that ginsenoside Rb1 significantly increased PPARγ
expression and enhanced the differentiation of 3T3-L1 preadipocytes at concentrations
between 1 and 50 µM, whereas Rg3 showed a maximal stimulatory effect at 1 µM with a
dose-dependent decrease at 10 and 50 µM concentrations (Figures 1 and 2). The ability
of Rb1 and Rg3 to increase PPARγ mRNA suggests that these ginsenosides may have
potential as a natural bioactive component for increasing insulin sensitivity. Our data also
indicate that Rb1 and Rg3 may confer insulin-sensitizing effects through the upregulation
of adiponectin and GLUT4 gene expression, leading to subsequent glucose uptake and
utilization in adipocytes. Interestingly, we also observed similar and comparable effects of
Rb1 and Rg3 co-treatment (in a ratio of 9:1) on GLUT4 and adiponectin gene expression
(Figure 5). It is worth noting that the ratio of Rb1 and Rg3 (9:1) that has a maximal
stimulatory effect on GLUT4 and adiponectin was similar to the profile we typically
observed in steamed or fermented ginseng (in a ratio of ~8:1).
One line of research suggests that adiponectin is an insulin-sensitizing hormone that
is expressed exclusively in adipocytes [49]. The mRNA expression of adiponectin and
its plasma levels in adipose tissue were highly correlated with obesity-induced insulin
resistance, which was reversed by the administration of adiponectin [50,51]. Further,
the insulin-sensitizing actions of TZDs are also known to be mediated by targeting PPARγ
and adiponectin in adipocytes [52,53]. A clear association between impaired adipocyte
differentiation and insulin resistance has been explained by the observation that TZDs
promote adipocyte differentiation, generating small adipocytes that are more insulin
sensitive than enlarged adipocytes [54]. It cannot be determined from the present study
whether ginsenoside Rb1, Rg3, or both increases the number of small adipocytes. However,
the ability of Rb1 and Rg3 to upregulate the expression of PPARγ, GLUT4, and adiponectin
mRNAs (Figures 2 and 3) may account for their anti-hyperglycemic effects observed
in vivo [55]. Although precise molecular mechanisms regulating GLUT4 and adiponectin
gene expression by Rb1 and Rg3 are not clear, they are presumably due to PPARγ activation
in adipocytes.
The insulin signaling pathway regulates glucose homeostasis by transducing insulin’s
signal to downstream intracellular target molecules, including IRS-1 and Akt. The subsequent activation of the PI3K pathway is necessary for the recruitment of GLUT4 to
the cell membrane, which will ultimately increase glucose uptake in insulin-sensitive
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tissues [56,57]. Our results show that upregulation of GLUT4 expression induced by individual and combined Rb1 and Rg3 correlated with the increased expression of IRS-1, Akt,
and PI3K mRNAs (Figures 4 and 6). Interestingly, the combined treatment of ginsenosides
Rb1 and Rg3 exerted more potent effects than individual treatments, which may suggest
a synergistic effect via differential chemical structures between ginsenoside Rb1 and Rg3
(Figures 5 and 6). Current findings are consistent with a previous report by Shang et al. [29],
where ginsenoside Rb1 stimulated glucose uptake through the insulin signaling pathway
in mature adipocytes. Moreover, Kim et al. [58] reported that enhanced glucose uptake and
insulin signaling pathway activity by ginsenoside Rg3 was induced, in part, by increasing
IRS-1 transcripts in L6 myoblasts.
5. Conclusions
In summary, ginseng is one of the most used medicinal herbs, and both ginseng
research and market demands have significantly increased in the past decades. Moreover,
red ginseng is more often consumed in various processed forms (67%) than unprocessed
ginseng products (33%) [59]. Given the recent findings that ginsenoside Rg3 is produced
from Rb1 by the human intestine as well as steaming/fermentation processes, our results
provide additional information for a possible mechanism of action of ginsenosides Rb1 and
Rg3 as well as their potential synergistic effects. However, further studies are needed to
identify the in vivo effects that Rb1 and Rg3 have on glucose and lipid metabolism using
different preclinical and clinical models.
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